Higher Body Mass Index Was Associated with Better Prognosis in Diabetic Patients with Stage II Colorectal Cancer
Overview
Affiliations
Purpose: The purpose of this study is to analyze the effect of body mass index (BMI) on patients with concurrent colorectal cancer (CRC) and type 2 diabetes mellitus (T2DM).
Methods: Patients who underwent primary radical CRC surgery from Jan 2011 to Jan 2020 were retrospectively collected. The perioperative information, overall survival (OS) and disease-free survival (DFS) were compared between the higher BMI group and the lower BMI group.
Results: A total of 574 patients with concurrent CRC and T2DM were included in this study. The higher BMI group had higher portion of hypertension (p < 0.01) and coronary heart disease (CHD) (p < 0.01). Furthermore, the higher BMI group had better OS (p = 0.016) and DFS (p = 0.040) than the lower BMI group in stage II CRC. In multivariate analysis, age (OS: p = 0.002, HR = 2.016, 95% CI = 1.307-3.109/ DFS: p = 0.003, HR = 1.847, 95% CI = 1.230-2.772), TNM stage (OS: p < 0.01, HR = 1.667, 95% CI = 1.281-2.169/ DFS: p = 0.001, HR = 1.545, 95% CI = 1.207-1.977), overall complications (OS: p = 0.004, HR = 1.837, 95% CI = 1.218-2.880/ DFS: p = 0.006, HR = 1.783, 95% CI = 1.184-2.686) and major complications (OS: p = 0.005, HR = 2.819, 95% CI = 1.376-5.774/ DFS: p = 0.014, HR = 2.414, 95% CI = 1.196-4.870) were independent factors of OS and DFS. Moreover, BMI (p = 0.019, HR = 0.413, 95% CI = 0.197-0.864) was an independent factor of OS in stage II CRC.
Conclusion: Higher BMI was associated with better OS in diabetic patients with stage II CRC.
Yang W, Zhou X, He G Front Oncol. 2025; 15:1440105.
PMID: 39944832 PMC: 11813759. DOI: 10.3389/fonc.2025.1440105.
Li L, Luo X, Shu X, Li Z, Liu F, Liu X JGH Open. 2024; 7(12):936-941.
PMID: 38162855 PMC: 10757490. DOI: 10.1002/jgh3.13005.
Tao W, Liu F, Cheng Y, Zhang B, Liu X, Zhang W Cancer Control. 2023; 30:10732748231210676.
PMID: 37982606 PMC: 10664434. DOI: 10.1177/10732748231210676.
Shu X, Xiang Y, Liu F, Cheng Y, Zhang W, Peng D BMC Cancer. 2023; 23(1):915.
PMID: 37770882 PMC: 10537469. DOI: 10.1186/s12885-023-11446-5.
Zhang B, Li Z, Tong Y, Yuan C, Liu X, Wei Z Int J Clin Oncol. 2023; 28(12):1616-1624.
PMID: 37700210 DOI: 10.1007/s10147-023-02410-1.